These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 9208017)

  • 1. [Cyclosporin in the treatment of chronic diseases of the liver (excluding transplantation)].
    Di Martino V; Cadranel JF; Erlinger S
    Gastroenterol Clin Biol; 1997; 21(5):400-11. PubMed ID: 9208017
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunological changes during the treatment of chronic liver diseases with immunosuppressive agents].
    Zivković R; Babić D; Radosević V; Sket-Janković N; Bogdan I; Vercko K; Varlaj V
    Acta Med Iugosl; 1976; 30(5):497-508. PubMed ID: 1015350
    [No Abstract]   [Full Text] [Related]  

  • 3. The impact of cyclosporine on the development of immunosuppressive therapy for pediatric liver transplantation.
    Burdelski MM
    Transplant Proc; 2004 Mar; 36(2 Suppl):295S-298S. PubMed ID: 15041356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporin treatment in three children with chronic inflammatory demyelinating neuropathy.
    Hergüner MO; Incecik F; Altunbaşak S
    Pediatr Neurol; 2009 Sep; 41(3):223-5. PubMed ID: 19664543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The anti-calcineurins (cyclosporin and tacrolimus)].
    Raymond S; Limat S; Woronoff-Lemsi MC
    Soins; 2007 Jun; (716):61-3. PubMed ID: 17718044
    [No Abstract]   [Full Text] [Related]  

  • 6. [Twenty-five years of cyclosporin use in transplantation medicine].
    Hesselink DA; van Hagen PM; Balk AH; van Hal PT; Weimar W; van Gelder T
    Ned Tijdschr Geneeskd; 2003 May; 147(20):959-64. PubMed ID: 12784529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is cyclosporin the immunosuppressant of choice for liver transplantation for erythropoietic protoporphyria?
    Nash KL; Cox TM; Alexander GJ
    Transpl Int; 2008 Feb; 21(2):192-3. PubMed ID: 17944799
    [No Abstract]   [Full Text] [Related]  

  • 8. Lack of interaction between raltegravir and cyclosporin in an HIV-infected liver transplant recipient.
    Di Biagio A; Rosso R; Siccardi M; D'Avolio A; Bonora S; Viscoli C
    J Antimicrob Chemother; 2009 Oct; 64(4):874-5. PubMed ID: 19643773
    [No Abstract]   [Full Text] [Related]  

  • 9. Chronic cyclosporin-induced nephropathy.
    Takahara S; Ota K; Takahashi K; Uchida K; Morozumi K; Wang JD; Kyo M;
    Clin Nephrol; 2001 Jan; 55(1):69-72. PubMed ID: 11200870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporin in steroid-resistant autoimmune hepatitis and HCV-related liver diseases.
    Fagiuoli S; Bruni F; Bravi M; Candusso M; Gaffuri G; Colledan M; Torre G
    Dig Liver Dis; 2007 Nov; 39 Suppl 3():S379-85. PubMed ID: 18063259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cyclosporine-based immunosuppressive therapy on liver histology of hepatitis C virus-infected renal transplant patients.
    Schiavon LL; Carvalho-Filho RJ; Narciso-Schiavon JL; Barbosa DV; Lanzoni VP; Ferraz ML; Silva AE
    Hepatology; 2008 Jul; 48(1):348-9. PubMed ID: 18521870
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolution of immunosuppression in liver transplantation: contribution of cyclosporine.
    Furukawa H; Todo S
    Transplant Proc; 2004 Mar; 36(2 Suppl):274S-284S. PubMed ID: 15041353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhaled cyclosporin suppresses chronic projection following lung transplantation].
    Gross H
    Pneumologie; 2006 Sep; 60(9):559. PubMed ID: 17006791
    [No Abstract]   [Full Text] [Related]  

  • 15. Sirolimus conversion for renal preservation in liver transplantation: not so fast.
    Jensen GS; Wiseman A; Trotter JF
    Liver Transpl; 2008 May; 14(5):601-3. PubMed ID: 18433068
    [No Abstract]   [Full Text] [Related]  

  • 16. [The use of cyclosporin A in the treatment of autoimmune disorders].
    Kurki P
    Duodecim; 1999; 115(6):659-66. PubMed ID: 11859500
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunosuppressive treatment in liver diseases].
    Ritland S
    Tidsskr Nor Laegeforen; 1983 Apr; 103(10):839-40. PubMed ID: 6879519
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in primary SPK transplantation: 3-year results of the Euro-SPK 001 trial.
    Saudek F; Malaise J; Boucek P; Adamec M;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii3-10, ii62. PubMed ID: 15814547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What significance has the C(2) value in the treatment with cyclosporin A?].
    Pham VV; Stichtenoth DO; Frölich JC
    Dtsch Med Wochenschr; 2004 Mar; 129(13):706. PubMed ID: 15026970
    [No Abstract]   [Full Text] [Related]  

  • 20. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.